Continuing Education | Contemporary Clinic

Real-World Data on Neovascular Age-Related Macular Degeneration: Preserving Vision Acuity While Decreasing Injection Burden of Anti-VEGF Treatments

October 27th 2021

This activity will focus on the appropriate consideration of emerging therapies to treat neovascular AMD, factors that contribute to decreasing the disease burden, and use of best practices in cost management.

Spinal Muscular Atrophy: Updates in Clinical Trial Data and What Managed Care Professionals Need to Know, featuring a Patient Perspective

October 27th 2021

This activity will characterize the pathogenesis of spinal muscular atrophy (SMA) including its clinical presentation, classifications, diagnosis, and the need for early intervention.

Advances in Early Cancer Detection: Insights for Managed Care Professionals

October 28th 2021

This activity will provide managed care professionals with an overview of trial data related to multicancer screening tests under development and discuss important considerations when incorporating such technologies into screening policies and procedures.

Adopting Oncology Biosimilars Into Clinical Practice: How Pharmacists Can Help Pave the Way

April 23rd 2021

This activity will apply knowledge of the challenges associated with the adoption of biosimilars into clinical practice to a real-world patient and clinician counseling scenario.

Examining Hemophilia Treatments: Updates for Specialty Pharmacists

October 15th 2021

This activity will present the latest research for individualizing therapy using pharmacokinetic parameters, along with the extended half-life products on the market as well as emerging therapies.

Chronic CAD and PAD: Reducing Major Adverse Cardiovascular Events With Dual Pathway Inhibition Antithrombotic Therapy

November 15th 2021

This activity will review guidelines for treatment of secondary prevention of CAD and PAD, as well as identification of when to recommend antithrombotic therapy, and counseling points pharmacists can provide to patients regarding lifestyle modifications for prevention of CAD and PAD.

Implementing Effective Protocols When Using Direct Oral Anticoagulant Reversal Agents: A Review of Updated Guidelines and Clinical Data

October 15th 2021

This article will analyze the mechanisms of action, safety and efficacy data, and adverse effects associated with the use of approved DOAC reversal agents.